CMMB: Chemomab Therapeutics Ltd. Expected earnings per share growth for next year

Public company logo of chemomab.com (CMMB)

The prospects for Chemomab Therapeutics (CMMB) are based on the development of therapies for rare fibrous pathologies, investor support, and orphan drug status. The development of monoclonal antibodies will ensure high margins and patent protection for the drugs. Analyzing the forward earnings per share growth forecast displayed on GURU.Markets, this chart shows that the metric has leveled off at 0.00, taking into account R&D risks and the burn rate.

Chemomab Therapeutics Ltd (CMMB): Net earnings per share change forecast for next year from 07/04/2022 to 11/16/2026

Analytical breakdowns and data insights for company Chemomab (CMMB)

- share price and consensus valuation forecast:
Fundamental company valuation:CMMB, Chemomab Therapeutics Ltd
Finished products of Chemomab Therapeutics Ltd

Identifying fundamentally resilient assets requires an analysis of consensus forecasts for future returns. This metric measures the expected dynamics of net income per share, reflecting market expectations for capital growth rates. For Chemomab Therapeutics (CMMB), which integrates sustainable ESG standards into drug development, the target net income per share growth rate serves as an indicator of the effectiveness of ethical compliance and cost optimization.

Analysis of competing companies

VRTX (Vertex) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ALNY (Alnylam)|Expected earnings per share growth for next year INSM (Insmed)|UTHR (United Therapeutics Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Net earnings per share change forecast for next year|BGM Group Ltd - Earnings growth forecast for next year|Expected earnings per share trend next year COGT (Cogent Biosciences)|XERS: Earnings growth forecast for next year|Keros Therapeutics Inc (KROS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Arcturus Pharma|ETON: Expected earnings per share trend next year|Net earnings per share growth forecast for next year kamada.com (KMDA)|Expected earnings per share growth for next year Fulcrum Therapeutics FULC|Earnings growth forecast for next year ABEO (Abeona Therapeutics, Inc.)|Earnings growth forecast for next year Mereo BioPharma MREO|PLX - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year PLRX|Applied Therapeutics (APLT) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Rein Therapeutics Inc (RNTX)|Net earnings per share growth forecast for next year Gelteq Limited|AYTU (Aytu BioPharma) - Projected earnings per share increase next year|Expected earnings per share growth for next year SRXH (SRx Health Solutions Inc)|PLRZ - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Aeterna Zentaris AEZS|Cyclo Therapeutics, Inc. (CYTH) - Expected net earnings per share growth next year|INZY - Net earnings per share growth forecast for next year|Expected earnings per share trend next year RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Net earnings per share growth forecast for next year